Hyundai Pharmaceutical Market Cap

Hyundai Pharmaceutical has a market cap or net worth of 254.63 billion as of March 19, 2026. Its market cap has increased by 165.51% in one year.

Market Cap

254.63B

Enterprise Value

n/a

Revenue

108.14B

Ranking

n/a

PE Ratio

152.47

Stock Price

9,440.00

Market Cap Chart

Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 254.63B, an increase of 784.92%. That is a compound annual growth rate of 7.39%.

Market Cap History

Date	Market Cap	% Change
Mar 19, 2026	254.63B	7.98%
Dec 30, 2025	235.81B	137.66%
Dec 30, 2024	99.22B	-12.77%
Dec 28, 2023	113.76B	-14.20%
Dec 29, 2022	132.58B	-19.22%
Dec 30, 2021	164.12B	-22.93%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Korea United Pharm	296.46B
JW Holdings	295.44B
BNC Korea	276.32B
Boditech Med	263.58B
CMG Pharmaceutical	251.63B
Ilyang Pharmaceutical Co.,Ltd	233.92B
Chong Kun Dang Holdings	233.51B
Suheung	224.61B

Market Cap Rankings